VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,031,000 | +21.9% | 245,653 | 0.0% | 0.82% | +41.3% |
| Q2 2016 | $4,948,000 | -28.2% | 245,653 | +0.2% | 0.58% | -27.4% |
| Q1 2016 | $6,889,000 | -72.3% | 245,083 | 0.0% | 0.80% | -69.1% |
| Q4 2015 | $24,913,000 | -43.1% | 245,083 | 0.0% | 2.57% | -41.5% |
| Q3 2015 | $43,804,000 | -28.4% | 245,083 | -10.9% | 4.40% | -24.9% |
| Q2 2015 | $61,170,000 | +126.6% | 275,083 | +5057.2% | 5.86% | +137.3% |
| Q1 2015 | $27,000,000 | – | 5,334 | – | 2.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |